Showing results (41-50 of 104) with videos related to
Sort By:
Pageof 11
Gan to Kagaku Ryoho. Cancer & Chemotherapy|March 12, 2020
[Five-Year Local Control by Stereotactic Body Radiation Therapy(SBRT)for Liver Metastasis from Colorectal Cancer-A Case Report]Mitsunori Ushigome, Kimihiko Funahashi, Kimihiko Yoshida, et al.Oncology Reports|January 1, 2010
Microsatellite instability at tetranucleotide repeats in sporadic colorectal cancer in JapanKanae Yamada, Shinsaku Kanazawa, Junichi Koike, et al.International Journal of Clinical Oncology|April 26, 2018
Multi-panel assay of serum autoantibodies in colorectal cancerMitsunori Ushigome, Yoshihiro Nabeya, Hiroaki Soda, et al.International Journal of Clinical Oncology|December 11, 2019
Changing pattern of tumor markers in recurrent colorectal cancer patients before surgery to recurrence: serum p53 antibodies, CA19-9 and CEAMitsunori Ushigome, Hideaki Shimada, Yasuyuki Miura, et al.Molecular and Clinical Oncology|December 28, 2020
Possible predictive significance of serum RalA autoantibodies on relapse-free survival in patients with colorectal cancerMitsunori Ushigome, Hideaki Shimada, Yoshihiro Nabeya, et al.Oncology Letters|August 5, 2024
Low serum creatine kinase level is associated with poor prognosis in patients with hepatocellular carcinoma: A retrospective single‑center studyYu Matsumoto, Yuichiro Otsuka, Rei Okada, et al.Gan to Kagaku Ryoho. Cancer & Chemotherapy|March 5, 2004
[Clinical significance of TS and DPD activities in colorectal carcinoma as a predictive factor of UFT sensitivity]Kimihiko Funahashi, Junichi Koike, Naoyasu Saito, et al.Molecular and Clinical Oncology|August 9, 2020
Prevalence of autoantibodies against Ras-like GTPases, RalA, in patients with gastric cancerTatsuki Nanami, Isamu Hoshino, Masaaki Ito, et al.Hepato-Gastroenterology|February 21, 2015
Potential tumor spread of lateral pelvic lymphatic flow in low rectal cancerKimihiko Funahashi, Junichi Koike, Hiroyuki Shiokawa, et al.Surgery Today|April 23, 2025
Association between the preoperative Midkine (+)/CEA (+) level and poor prognosis in colorectal cancer patientsMitsunori Ushigome, Hideaki Shimada, Masaaki Ito, et al.Pageof 11